$24.55
1.52%
Nasdaq, Aug 29, 10:07 pm CET
ISIN
US45166A1025
Symbol
IDYA

IDEAYA Biosciences Inc Stock price

$24.55
-0.29 1.17% 1M
+3.98 19.35% 6M
-1.15 4.47% YTD
-14.62 37.32% 1Y
+14.95 155.73% 3Y
+12.45 102.89% 5Y
+13.36 119.39% 10Y
+13.36 119.39% 20Y
Nasdaq, Closing price Fri, Aug 29 2025
-0.38 1.52%
ISIN
US45166A1025
Symbol
IDYA
Industry

Key metrics

Basic
Market capitalization
$2.2b
Enterprise Value
$1.5b
Net debt
positive
Cash
$669.7m
Shares outstanding
87.6m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
307.4 | 189.4
EV/Sales
211.7 | 130.4
EV/FCF
negative
P/B
2.2
Financial Health
Equity Ratio
94.2%
Return on Equity
-25.9%
ROCE
-39.0%
ROIC
-
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$7.0m | $11.4m
EBITDA
$-382.0m | $-320.1m
EBIT
$-384.4m | $-336.4m
Net Income
$-331.3m | $-302.7m
Free Cash Flow
$-297.0m
Growth (TTM | estimate)
Revenue
-41.5% | 62.3%
EBITDA
-102.1% | 1.4%
EBIT
-100.8% | -2.9%
Net Income
-115.2% | -10.3%
Free Cash Flow
-120.5%
Margin (TTM | estimate)
Gross
-
EBITDA
-5,456.5% | -2,817.7%
EBIT
-5,491.7%
Net
-4,733.0% | -2,664.6%
Free Cash Flow
-4,242.1%
More
EPS
$-3.8
FCF per Share
$-3.4
Short interest
13.0%
Employees
131
Rev per Employee
$50.0k
Show more

Is IDEAYA Biosciences Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,011 stocks worldwide.

IDEAYA Biosciences Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

22 Analysts have issued a IDEAYA Biosciences Inc forecast:

19x Buy
86%
3x Hold
14%

Analyst Opinions

22 Analysts have issued a IDEAYA Biosciences Inc forecast:

Buy
86%
Hold
14%

Financial data from IDEAYA Biosciences Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
7 7
41% 41%
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 49 49
48% 48%
703%
- Research and Development Expense - -
-
-
-382 -382
102% 102%
-5,457%
- Depreciation and Amortization 2.47 2.47
2% 2%
35%
EBIT (Operating Income) EBIT -384 -384
101% 101%
-5,492%
Net Profit -331 -331
115% 115%
-4,733%

In millions USD.

Don't miss a Thing! We will send you all news about IDEAYA Biosciences Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

IDEAYA Biosciences Inc Stock News

Neutral
PRNewsWire
3 days ago
SOUTH SAN FRANCISCO, Calif. , Aug. 29, 2025 /PRNewswire/ -- IDEAYA Biosciences, Inc. (Nasdaq: IDYA), a leading precision medicine oncology company, today announced that an abstract with data from the company's single-arm, Phase 1/2 trial of darovasertib in combination with crizotinib in first-line metastatic uveal melanoma (mUM) was accepted for an oral presentation at the 2025 Society for Mela...
Neutral
PRNewsWire
3 days ago
SOUTH SAN FRANCISCO, Calif. , Aug. 29, 2025 /PRNewswire/ -- IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a precision medicine oncology company committed to the discovery and development of targeted therapeutics, today announced that, on August 28, 2025, the Compensation Committee of IDEAYA's Board of Directors granted non-qualified stock options to purchase an aggregate of 139,800 shares of the Com...
Neutral
PRNewsWire
7 days ago
SOUTH SAN FRANCISCO, Calif. , Aug. 25, 2025 /PRNewswire/ -- IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a precision medicine oncology company committed to the discovery and development of targeted therapeutics, announced its participation in the upcoming investor relations events.
More IDEAYA Biosciences Inc News

Company Profile

IDEAYA Biosciences, Inc. engages in the research and development of oncology-focused precision medicine. The firm focuses on targeted therapeutics for patients selected using molecular diagnostics. Its product candidate, IDE196, is a protein kinase C inhibitor for genetically-defined cancers having GNAQ or GNA11 gene mutations. The company was founded by Yujiro S. Hata and Jeffrey Hager in June 2015 and is headquartered in South San Francisco, CA.

Head office United States
CEO Yujiro Hata
Employees 131
Founded 2015
Website www.ideayabio.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today